Nutritional Status Driving Infection by Trypanosoma cruzi: Lessons from Experimental Animals by Malafaia, Guilherme & Talvani, André
Hindawi Publishing Corporation
Journal of Tropical Medicine
Volume 2011, Article ID 981879, 11 pages
doi:10.1155/2011/981879
Review Article
Nutritional Status Driving InfectionbyTrypanosomacruzi:
Lessons fromExperimental Animals
GuilhermeMalafaia1 andAndr´ eT al vani 2
1Departamento de Ciˆ encias Biol´ ogicas, N´ ucleo de Pesquisas e Estudos Ambientais e Biol´ ogicos, Instituto Federal de Educac ¸˜ ao,
Ciˆ encia e Tecnologia Goiano—Campus Uruta´ ı, Rodovia Geraldo Silva Nascimento km 2.5, 75790-000 Uruta´ ı, GO, Brazil
2Laborat´ orio de Doenc ¸a de Chagas, Programa de P´ os-Graduac ¸˜ ao em Ciˆ encias Biol´ ogicas, N´ ucleo de Pesquisa em Ciˆ encias Biol´ ogicas
(NUPEB), Universidade Federal de Ouro Preto (UFOP), 35400-000 Ouro Preto, MG, Brazil
Correspondence should be addressed to Guilherme Malafaia, guilhermebioufop@yahoo.com.br
Received 3 September 2010; Revised 30 November 2010; Accepted 17 February 2011
Academic Editor: R. Corrˆ ea-Oliveira
Copyright © 2011 G. Malafaia and A. Talvani. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Thispaperreviewsthescientiﬁcknowledgeaboutprotein-energyandmicronutrientmalnutritioninthecontextofChagasdisease,
especially in experimental models. The search of articles was conducted using the electronic databases of SciELO (Scientiﬁc
Electronic Library Online), PubMed and MEDLINE published between 1960 and March 2010. It was possible to verify that
nutritional deﬁciencies (protein-energy malnutrition and micronutrient malnutrition) exert a direct eﬀect on the infection by
T. cruzi. However, little is known about the immunological mechanisms involved in the relationship “nutritional deﬁciencies and
infection by T. cruzi”. A hundred years after the discovery of Chagas disease many aspects of this illness still require clariﬁcation,
including the eﬀects of nutritional deﬁciencies on immune and pathological mechanisms of T. cruzi infection.
1.Introduction
The protein-energy malnutrition (PEM) and micronutrient
malnutrition (MNM) are common problems worldwide
and occur in both developing and developed nations. In
the developing world, it is a reﬂection of socioeconomic,
political, or environmental factors, and, in developing coun-
tries, PEM usually occurs in the context of chronic diseases
[1]. Chagas disease is a chronic parasite illness caused by
the hemoﬂagellate protozoan Trypanosoma cruzi,a ﬀecting
millions of people in developing nations in the South and
Central Americas. It is estimated that 15-16 million people
are infected with T. cruzi in Latin America and 75–90
million are at risk of infection [2]. Due the prevalence of
Chagas disease and PEM-MNM together, they are, directly
or indirectly, responsible for millions of deaths worldwide
[3, 4].
PEM is a major public health problem in the tropical
and subtropical regions of the world and often arises during
protein and/or energy deﬁcit due to nutritional inadequacy,
infections, and poor socioeconomic and environmental
conditions [3]. It is the most common nutritional disorder
aﬀecting children in developing countries and the third most
common clinical disorder of childhood in such countries.
PEM has a lasting eﬀect on immune functions, growth and
development of children, learning ability, social adjustment,
work eﬃciency, and productivity of labor. It seems that
many deaths from PEM occur as a result of outdated clinical
practices, and an improving of these practices appears to be
essential to reduce this rate of morbidity and mortality [5].
PEM is responsible, directly or indirectly, for 54% of the 10.8
milliondeathsperyearinchildrenunder5andcontributesto
every second cause of death (53%) associated with infectious
diseases among children under 5 years of age in developing
countries [1]. However, PEM is also observed in adults.
According to Sawaya [6], adults who have an inadequate
food intake may have an increased susceptibility to diseases,
including infectious diseases, weight loss, low immunity,
damage to the gastrointestinal mucosa, loss of appetite, poor
absorption of nutrients, and major changes in metabolism.
In addition, adult PEM hospitalized patients are a highly
prevalent reality, having as direct consequences the increase2 Journal of Tropical Medicine
of morbidity and mortality, drawn-out hospitalization time,
and, therefore, raising the costs for the health system [7–
10].Alltheseconsequencesprovidesocial,physiological,and
psychological damage in adults.
Another clinical condition that also represents an impor-
tant issue to the nutritional disorders is the MNM (including
vitamins and trace minerals deﬁciencies). From the public
health point of view, MNM is a risk factor for many other
acute and chronic diseases and can contribute to high rates
of morbidity and even mortality. It has been estimated that
micronutrient deﬁciencies account for about 7.3% of the
global burden of disease, with iron and vitamin A deﬁciency
ranking among the 15 leading causes of the global disease
burden [11].
According to some authors, there is a close association
between PEM/MNM and increased severity of infections by
various infectious organisms [12–17], including HIV/AIDS
[18], tuberculosis [19], malaria [20], and leishmaniasis [21–
23]. Despite this new evidence about nutritional deﬁciencies
and host immune response against protozoan, few studies
have been developed about the T. cruzi infection. However,
the distribution of T. cruzi infection overlaps regions with
high prevalence of PEM, as we can see, for instance, in the
study of De Andrade and Zicker [24].
Thus, the purpose of this paper is to provide an update
on what is known about the synergy between Chagas disease
and nutritional deﬁciencies (PMN and MNM), especially in
experimental models, and discuss the main studies involving
both diseases. Since nutritional deﬁciency and T. cruzi
infectionarefrequentseriousproblemscurrently,wewonder
whether a one-way dietary intervention might be useful to
eliminate PMN and MNM and, indirectly, beneﬁt T. cruzi-
infected host mammalians under speciﬁc treatment or not.
2.Methodology
For this study, a bibliographical search was used, includ-
ing empirical reports, reviews, comments, reports from
professional associations, books, editorials, and annals of
congresses published in diverse languages. The search of
articles was conducted using the electronic databases of
SciELO (Scientiﬁc Electronic Library Online), PubMed, and
MEDLINE published between 1960 and March 2010. For
selection of scientiﬁc papers, the following criteria were
used: (i) papers about PEM, MNM, and Chagas disease,
considering the speciﬁc aspects on these diseases; (ii) papers
about the epidemiology and prevalence of PEM, MNM,
and Chagas disease; (iii) studies published in specialized
magazines with considerable impact. The following search
terms were used on their own and in combination: “Cha-
gas disease,” “Trypanosoma cruzi,” “malnutrition,” “protein-
energy malnutrition,” “micronutrient malnutrition,” “pro-
tein deﬁciency”; “vitamins deﬁciency”; “iron deﬁciency,”
“zinc deﬁciency” and “selenium deﬁciency”. All retrieved
studies were evaluated by reading the abstracts; and full
papers were retrieved for articles that could not be rejected
basedonabstractalone.Referencesfromtheretrievedpapers
were also manually searched for additional relevant studies.
Descriptive studies were considered, those that described
the epidemiology, prevalence, and pathology of Chagas dis-
ease and/or PEM/MNM. The studies on determination were
considered, those that explored, directly or indirectly, the
relationship between the PEM, MNM, and Chagas disease.
Furthermore, studies that described the consequences of
PEM and MNM on the immune system were also consulted
to base the discussion.
3. Results and Discussion
3.1. Epidemiology, T. cruzi Infection, and Clinical Evolution:
General Aspects. As revised by Coura and Dias [2], Chagas
disease originated millions of years ago as an enzootic
infection of wild animals and began to be transmitted
to humans as an anthropozoonosis when man invaded
wild ecotopes. While evidence of human infection has
been found in mummies up to 9,000 years old, endemic
Chagas disease became established as a zoonosis only in
the last 200–300 years, as triatomines adapted to domestic
environments [25]. The geographical distribution of Chagas
disease, including its reservoirs and its vectors, extends
from the Southern United States to Southern Argentina
and Chile. Thus, it covers all Americas, and 90 million
people in this region are exposed to infection. It is currently
estimated that 15 million people present T. cruzi infection
or carry the disease [2]. In Brazil, for example, recent
data from the Brazilian Ministry of Health conﬁrmed the
occurrence of 2,476 cases (1,603 vectorial, 16 transfusional,
and 7 transplacentary transmission, as well as 850 cases of
nonidentiﬁed form of transmission) of acute Chagas disease
from 2001 to 2006 with 95 deaths. Furthermore, recently
the transmission of Chagas disease by oral route has gained
evidence through the consumption of Ac ¸a´ ı, the fruit of a
palm of the family Aracaceae, especially among Amazonian
population that consumes ac ¸a´ ı juice daily. It is believed that
the contamination occurs when inadvertently triatomines
are crushed during processing releasing infective forms of
parasites stationed in their stools. Besides, consumption of
raw meat from infected mammalian sylvatic hosts is also
described for Chagas oral transmission [26].
There is a general consensus that during chronic
T. cruzi infection, the host immune system induces complex
processes to ensure the control of parasite growth while
preserving the potential to mount and maintain a life-long
controlled humoral and cellular immune response against
the invading pathogen. Recently, increasing focus on innate
immunity suggests that chronic T. cruzi infection may cause
morbidity when innate eﬀectors functions or the downregu-
lation of adaptive regulatory mechanisms are lacking [27]. In
this context, stable asymptomatic host-parasite interactions
seem to be inﬂuenced by the eﬀector/regulatory balance
with the participation of macrophages, natural killer (NK)
and CD8+ T cells in parallel with the establishment of
regulatory mechanisms mediated by natural killer T (NKT)
and regulatory T (Treg) cells. Moreover, a balanced innate
immune activation state, apart from Treg cells, may play a
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antigen release induced by trypanosomicidal agents during
Chagas disease etiological treatment.
The determinants of Chagas disease come from the
quantity of parasites in the initial infection (number of
trypomastigotes), the lineage of the inoculated T. cruzi (I, II,
Z3, or hybrid I/Z3, today reclassiﬁed as TcI–TcVI), the rein-
fections, the quality of the strains and clones (biodemes); the
speciﬁc clonal-histotrophic receptors, and the mammalian
host immune response [28–32].
After T. cruzi infection, this disease presents two suc-
cessive phases: acute and chronic. Acute infection is often
asymptomatic or may manifest as a self-limited febrile illness
that lasts 4–8 weeks. Clinical manifestations of chronic
Chagas disease are related to the pathologic involvement of
the heart, esophagus, and/or colon [32, 33]. Parasites play a
fundamental role in the genesis and development of organs
lesions by sequentially inducing an inﬂammatory response,
cellular and tissue lesions, and ﬁbrosis [34].
Complexities of the pathology of Chagas disease and
the diversity of its clinical manifestations have made
the understanding of its pathogenesis diﬃcult. However,
the inﬂammatory background (cellular, humoral, and/or
autoimmune responses) concerning this disease has been
largely investigated, especially in cardiac tissue. The inﬁltrate
in chronic Chagas heart disease consists of lymphocytes, and
to a lesser extent, macrophages, eosinophils, plasma cells,
neutrophils, and mast cells. T cells predominate and CD8+
lymphocytes are two to three times more abundant than
CD4+ cells [35]. The most part of this leukocyte recruitment
into the heart tissue is driven by chemokine and chemokine
receptors and, their overexpression is clearly associated with
heart dysfunction [36–38]. The perpetuation of leukocyte in
parasites is rarely found in the heart but parasite DNA can be
detected in some inﬂammatory lesions. Myocyte destruction
is followed by dissolution of the inﬂammatory cell inﬁltrate
and replacement with connective tissue. This ﬁbrosis is
composed by collagen types I and III and, over the years,
is thought to be responsible for decreased contractility of
the heart, diminished cardiac muscle mass, and destruction
of the intrinsic innervations. Lesions similar to those in
the myocardium are found in both the epicardium and the
endocardium.
3.2. Evidences of Relation between Nutritional Deﬁciencies
and T. cruzi Infection. The ﬁrst critical report describing
malnutrition and infectious disease related to mortality and
morbidity was probably by Scrimshaw et al. [39]. This
topic suggests a vicious cycle involved, in which PEM/MNM
increases the susceptibility to infections [16]. In response to
infection, the immune system ﬁrst executes innate defense
functions and then subsequently acquired host defense
functions of great diversity. Both processes involve activation
of immune cells and synthesis of an array of molecules
requiring DNA replication, RNA expression, and protein
synthesis, and secretion and therefore consume additional
anabolic energy. Mediators of inﬂammation further increase
the catabolic response. Consequently, the nutritional status
of the host critically determines the outcome of infection.
Almost all nutrients in the diet play a crucial role in
maintaining an “optimal” immune response; then deﬁciency
can have negative consequences on immune status [40]
and susceptibility to a variety of pathogens [41], including
T. cruzi.
3.3. Protein Deﬁciency and Infection by T. cruzi . Regarding
protein deﬁciency and T. cruzi infection, only the studies of
Machado et al. [42], Gomes et al. [43], Carlomagno et al.
[44], and Cintra et al. [45] (involving experimental models),
and De Andrade and Zicker [24] (involving human) were
found. Machado et al. [42] studied the relation between the
cardiac noradrenalin and the PEM in chronic experimental
Chagas disease in rats (in this case, no immune interaction
was evaluated). The results indicate that protein deﬁciency at
least delays the recovery of noradrenalin levels that normally
occurs during the chronic phase of experimental Chagas
disease.
The study of Gomes et al. [43]w a sc o n d u c t e dt od e t e r -
mine the eﬀects of severe protein restriction (4.75, 9.5, 14.25
and 19% of protein in isocaloric diets with normal content
of mineral and vitamins) on parasitemia and mortality of
mice acutely infected with Y and CL strains of T. cruzi.
Only severe protein restriction (4.75%) induced decrease in
resistance to the infection with both Y and CL strains of
T. cruzi, which resulted in higher parasitemia and mortality.
The inﬂammatory lesions in heart and skeleton muscle were
lessextensiveingroupswithsevereproteinrestrictiondespite
the increased number of parasite in muscle cells. According
to authors, depression of immune mechanisms could be
responsible for the reduced resistance and inﬂammatory
reaction after T. cruzi infection in highly protein-restricted
animals.However,authorsdidnotperformanyevaluationof
immune response or inﬂammatory response to prove these
evidences. In this case, considering that the micronutrients
and macronutrients favor an adequate immune response
and that they are necessary for cell proliferation and
production of antibodies and other immune proteins, it is
questionable whether malnourished patients can regulate
their immune response and, thus, would not be harmed
by inﬂammatory response. There are no studies concerning
these aspects.
In order to determine if dietary proteins are responsible
for alterations in the course of T. cruzi infection in calorie
depleted mice, Carlomagno et al. [44] measured the eﬀects
of diets with reduced protein contents in the same animal
model. BALB/c mice receiving 20% (NP) or 2% (LP)
protein diets were injected with 100 blood trypomastigotes
15 days after diet starts. Onset of parasitemia was detected
earlier in the LP group, but on day 13th post infection
(pi), parasitemia levels, as well as survival time, were not
statistically diﬀerent from NP animals. Although a chronic
state could not be reached with animals infected with 15
blood trypomastigotes and receiving a 6% (SP) protein diet,
those animals sacriﬁced at 30 days pi showed statistically
diﬀerent DTH indexes, but not diﬀerent speciﬁc antibody
titers,comparedtoNPanimals.Todeterminetheeﬀectofthe
moderate protein deﬁciency upon the degree of protection4 Journal of Tropical Medicine
conferred by a ﬂagellar fraction (FF) of T. cruzi which
protects well-nourished animals against a lethal challenge of
theparasite,SPandNPmiceimmunizedwith5weeklydoses
of FF were challenged with 1000 metacyclic trypomastigotes.
Blood parasite levels were higher for vaccinated SP animals
compared to NP controls. Survival was also signiﬁcantly
lower for animals receiving the low protein diet.
Cintra et al. [45] have studied the inﬂuence of dietary
protein on T. cruzi infection in germ-free (GF) and conven-
tional (CV) mice. To do so, GF and CV mice were fed on
diets containing 4.4, 13.2, or 26.4% of protein. The protein
deﬁciency aﬀected less the GF than the CV mice regarding
weight gain, hemoglobin, plasma protein and albumin levels
and water and protein contents of the carcass. However, in
the presence of T. cruzi,G Fm i c ew e r em o r ea ﬀected by this
dietary, reducing hemoglobin levels, red blood cell count,
and water and protein contents in the carcass.
In a human study, De Andrade and Zicker [24] examined
the possible association between T. cruzi infection and
chronic PEM in Brazilian children. In a cross-sectional
survey conducted in the 1900s involving 153 children 7–
12 years old from 60 village schools in central Brazil
presenting positive serology to Chagas disease, seropositive
children had a 2.4-fold risk (95% CI 1.4–4.0) of being
stunted (z-score < 2.0 of height-for-age) when compared
to uninfected children even after adjusting for confounding
variables. Being underweight (z-score < −2.0 of weight-for-
age) was also statistically associated with seropositivity to
T. cruzi (OR = 2.8, 95% CI 1.4–5.6). Results of this study
suggested that further studies on nutrition and metabolism
are required to look into a possible physiopathological
mechanism for this association. Moreover, with these studies
we can venture the following questions: would the protein
deﬁciency be, in part, responsible for the worsening of
Chagas disease? Or may T. cruzi infection lead hosts to nutri-
tional deﬁciency? Changes in the digestive tract are described
in individuals with Chagas disease [46]. In these cases,
such changes may lead patients to nutritional deﬁciencies,
changing the digestion and/or absorption of micronutrients
and macronutrients. After more than 10 years of publication
of the paper by De Andrade and Zicker [24], little is still
known about this subject.
Despite few studies mentioning aspects concerning
“Chagas disease and protein deﬁciency,” there is no
doubt that protein deﬁciency aﬀects general immunological
aspects, which together may interfere in those malnourished
Chagas disease patients aﬀecting “host-parasite” interac-
tions. Regarding innate immunity, there are multiple and
interconnected mechanisms interfering in microbial infec-
tions such as phagocytosis, NK cells, complement-mediated
lysis, and opsonization. Anstead et al. [21], studying the
eﬀect of the malnutrition on innate immunity and early
visceralization following Leishmania donovani infection,
observed that malnutrition caused a failure of lymph node
barrier function after L. donovani infection, which may be
related to excessive production of prostaglandin E2 (PGE2)
and decreased levels of IL-10 and nitric oxide (NO). In
the occasion, a murine model of polynutrient deﬁciency
(diets deﬁcient in iron, zinc, and calories) demonstrated
that malnourished mice had altered innate immune defense
indicating an increased risk of visceralization following L.
donovani infection.
Later, the study of Anstead et al. [47] demonstrated
that, after stimulation with IFN-γ/LPS, macrophages from
malnourished mice, as compared with their well-nourished
control mice counterparts, produced less TNF-α, IL-10,
and NO. According to the authors, the deﬁcits in TNF-
α expression and low production of NO have signiﬁcant
consequencesinhostdefense.NO,forinstance,isanessential
regulatory molecule in host protective responses, acting as
a potential host-destructive mediator in severe pathologies,
mainly in infectious diseases. Besides, the low levels of IL-10
produced by the macrophages from the malnourished mice
may have adverse eﬀects on the innate immune response
[47].
Abe et al. [48] demonstrated that, in mice with exper-
imental PEM, phagocytosis and production of reactive
oxygen intermediates (ROIs) and reactive nitrogen interme-
diates (RNIs) released by macrophages were diminished, as
well as the function of antigen presentation to T cells by
dendritic cells. PEM in mice, challenged by experimental
peritonitis, resulted in impaired immune cell migration
and extravasation as indicated by reduced numbers of
CD11b/CD18+ cells at the site of infection, involving lower
concentrations of the chemokine MIP-2 or CXCL2.
In humans, there is a close-to-normal neutrophil chemo-
taxis and phagocytosis and minor defects in the generation
of ROIs and bacterial killing in malnourished patients [49].
A signiﬁcant depression of serum opsonin activity [50]
explains these changes. All components of the complement
system—except C4—have been observed to be depressed in
malnourished patients, particularly C3 and factor B [51].
The NK cells are considered particularly important in
viral diseases, but they may also be important in resistance
to some prokaryotic intracellular parasites, such as T. cruzi
[52–54]. Early ﬁndings of depressed NK cell lytic activity in
blood mononuclear cells of children with PEM have been
extended from a study of protein-deﬁcient weanling mice
[55]. Surface marker analysis revealed that the low NK cell
lyticactivityofsplenicmononuclearcellsuspensionsresulted
from a depression in lytic cellular activity.
Regarding adaptive defenses, the mechanisms of action
resulting from protein deﬁciency on this system are also
multiple. Keusch et al. [56] reported that, in malnourished
children, there was a signiﬁcant decrease in T-cell function
and an increase in null cells that apparently failed to further
diﬀerentiate. The structure and function of the thymus
were damaged, and T-cell memory response to antigens was
reduced [57].
According to Woodward [58], lymphoid involution, as
indicated by the size and cellularity of secondary lymphoid
organs,isacharacteristicofPEM,andaccordingtoitsdegree
there is a depression in adaptive immunocompetence. At
the same time, the recirculating (i.e., surveillance) pool of
lymphocytes in a weanling mouse model of wasting protein
deﬁciency indicates that measures of lymphoid organ size
may yield an inﬂated impression of the extent of lymphoid
involution in PEM [58].Journal of Tropical Medicine 5
Imbalance among critical subsets of lymphocytes may
also contribute to the initiation or the continuation of
PEM-inducedimmunodepression.PEMleadstolong-lasting
immune defects characterized by leucopenia, decrease of
CD4/CD8 ratio and increase number of CD4/CD8 double-
negative T cells, and, therefore, the appearance of immature
T cells in the periphery [59]. Circulating T lymphocytes
from infected children with PEM had lower expression of
the activation marker CD69 and predominantly showed an
intermediate (CD45RAlow/CD45ROlow) rather than a mem-
ory phenotype (CD45ROhigh) when compared to healthy
donors [60, 61] .T h e s eTc e l l sw e r eb i a s e dt o w a r d st y p e2T
helper cell (Th2) responses, represented by decreased IFN-
γ/IL-2 (T helper cell—type 1/Th1) phenotype and increased
IL-4/IL-10 (type-2—Th2) production [62]. Experimentally
undernourished weanling mice had predominantly T cells
of the na¨ ıve quiescent phenotype (CD45RA+/CD62L+)[ 63,
64], where IFN-γ responses were depressed and IL-10 and
the Th2-associated antibody, IgE, were increased, while IL-4
production remained normal [65].
Antibody production in malnourished individuals seems
to be depending on the types of antigens involved. Mal-
nourished patients appear to respond well to tetanus [66]
and ﬂagellar antigens but not to the polysaccharide antigens
[67], which suggests that there is a defect in response to car-
bohydrates. Reduced antibody responses to polysaccharide
antigens of encapsulated bacteria such as Streptococcus pneu-
moniae and Haemophilus inﬂuenzae exacerbate susceptibility
to these pathogens [68].
3.4. Vitamin Deﬁciency and Infection by T. cruzi
3.4.1. Vitamin or Complex B. Vitamins are essential con-
stituents of our diet that have long been known to inﬂuence
the immune system [69]. Concerning the studies conducted
on the theme “vitamins deﬁciency and T. cruzi or Chagas’s
disease,” the pioneering study of Yaeger and Miller [70]
was conducted to determine the eﬀect of thiamine (vitamin
B1) deﬁciency on T. cruzi infections in albino rats. The
following conclusions were drawn from vitamin B1-deﬁcient
rats: (i) parasitemia were generally higher than in control
groups and (ii) cardiac lesions were more extensive and
tissue parasites more common, suggesting once more that
the presence of the etiologic agent in concomitance with the
nutritional deﬁciency status changes completely the course
of the disease.
However, few studies exist about eﬀects of vitamin
B1 deﬁciency on immune system, which could explain
the susceptibility of vitamin B1-deﬁcient rats to T. cruzi
infection. It is known that the active form of thiamine is
essential for its coenzyme functions in carbohydrate and
branched chain amino acids metabolisms. The thiamine
pyrophosphate is essential in decomposition reactions of
glucose in energy. Albino rats maintained for 13 weeks on
a riboﬂavin- (vitamin B12) deﬁcient diet did not exhibit
a signiﬁcant increase in susceptibility to T. cruzi infection.
The slight increase in severity of infection as evidenced by
cardiac damage and higher parasitemia was attributed to
inanition rather than to deﬁciency of the vitamin [71]. On
the other hand, when pantothenate (vitamin B5) deﬁciency
was used on the T. cruzi infection, also in albino rats,
it was observed that (i) T. cruzi produced more severe
infections in vitamin B5-deﬁcient rats than in normal ones
and inanition control groups of rats (ii) parasitemia was
higher and cardiac lesions were usually more extensive in the
vitamin B5-deﬁcient animals, and, ﬁnally, (iii) the incidence
of lung infections among vitamin B5-deﬁcient rats suggests
that this deﬁciency may increase the susceptibility of rats to
spontaneous respiratory disease [72]. This same investigative
group also demonstrated that rats maintained on a diet
from pyridoxine (vitamin B6) and vitamin A, were more
susceptible to T. cruzi infection, with higher parasitemia and
myocarditis [73, 74].
Early stages of vitamin B1 deﬁciency may be accompa-
nied by nonspeciﬁc symptoms that may be overlooked or
easily misinterpreted [75]. The clinical signs of deﬁciency,
in human, include anorexia, weight loss, mental changes
such as apathy, decrease in short-term memory, confusion,
and irritability, muscle weakness, and cardiovascular eﬀects
such as an enlarged heart [76–79]. The central nervous
system damage induced by vitamin B1 deﬁciency seems to
be simultaneously brought by (i) an increase in free radical
production, (ii) oxidative stress, (iii) axonal membrane
damage,(iv)disturbedmyelinogenesis,(v)selectiveneuronal
death, and (vi) glutamatemediated excitotoxicity [80–82].
Vitamin B1 deﬁciency also severely aﬀects the peripheral
nervous system [83].
Equally important is the role of vitamin B6 in the
immune functions. As revised by Rall and Meydani [84],
animal and human studies suggest that vitamin B6 deﬁ-
ciency aﬀects both humoral and cell-mediated immune
responses. Lymphocyte diﬀerentiation and maturation are
altered by deﬁciency, delayed-type hypersensitivity responses
are reduced, and antibody production may be indirectly
impaired. In addition, deﬁciency of the vitamin has been
associated with immunological changes observed in the
elderly, persons infected with human immunodeﬁciency
virus (HIV), and those with uremia or rheumatoid arthritis.
3.4.2. Vitamin A. It is known that the vitamin A deﬁciency
impairs innate immunity [85], which is important for the
control of Chagas disease [27]. According to Stephensen
[85], the vitamin A deﬁciency impairs innate immunity by
impeding normal regeneration of mucosal barriers damaged
by infection, as well as by diminishing the function of
neutrophils, macrophages, and natural killer cells. Vitamin
A is also required for adaptive immunity and plays a role in
the development of both T helper (Th) and B cells. In par-
ticular, vitamin A deﬁciency diminishes antibody-mediated
responses directed by Th2 cells, although some aspects of
Th1-mediated immunity are also diminished. In addition,
Mucida et al. [86] have recently shown that the vitamin
A metabolites, including retinoic acid (RA) and ligands
for retinoic acid-related nuclear receptors, play pleiotropic
roles in various biological processes. Authors described that
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factor-beta- (TGF-beta-) driven immune deviation, capable
of suppressing the diﬀerentiation of interleukin-17 secreting
T helper cells (T(H)17) and conversely promoting the
generation of Foxp3(+) T regulatory (Treg) cells.
3.4.3. Vitamin E. More recently, another study with vitamin
E deﬁciency was shown in experimental acute phase of Cha-
gas disease [87]. Using rats, authors observed that vitamin
E deﬁciency induced the decline in CD45RA+CD3− Bc e l l s
and CD3+CD4+ T lymphocytes in the peripheral blood and
an exacerbation of myocarditis and sympathetic denervation
of ventricles [87]. These results are in agreement with data
from Moriguchi et al. [88], demonstrating that vitamin E
deﬁciency results in low diﬀerentiation of T lymphocytes
in the thymus, mainly in CD4+ T cells. The essential role
of these two cellular populations in resistance to T. cruzi
infection is well known from the literature [89, 90]. During
T. cruzi acute infection, the antibody response mounted
by the host, which is essential to be strictly dependent on
the help provided by (or on the activation of) CD4+ T-
lymphocytes activation, is decisive for the outcome of the
infection[91].Carvalhoetal.[87]alsoobservedthatvitamin
E deﬁciency induced monocytosis, as well as an increased
diﬀerentiationrateofmonocytestomacrophages,asrevealed
by immunohistochemistry. In summary, these observations
point to an increased tissue parasitism in vitamin E-deﬁcient
rats. This may suggest that vitamin E deﬁciency induces an
exacerbationofinﬂammatorystatusduring T.cruziinfection
and an enhancing of components of the inﬂammatory
response, for example, the secretion of proinﬂammatory
cytokines by macrophages [92–96].
3.5. Iron or Zinc Deﬁciency and T. cruzi Infection. Regarding
the immune system, several studies have pointed to the
importance of iron, mainly because they ﬁnd that iron deﬁ-
ciency leads to defects in both adaptive and innate response,
causing reduction in the phagocytosis by neutrophils, in the
activation of T cells and, also, inducing signiﬁcant changes in
the cytokines production [97–99].
Lalonde and Holbein [100] were the ﬁrst to report
the inﬂuence of iron status on pathogenicity of T. cruzi
in C57BL/6 and C3H mice using a promoter of iron
deﬁciency—the iron chelator desferrioxamine. These
authors demonstrated that a reduction of intracellular iron
stores reduced the pathogenicity of T. cruzi infection, both
in the moderately resistant C57Bl/6 mouse strain and in the
highly susceptible C3H strain.
Pedrosa et al. studied the eﬀect of iron deﬁciency and
iron overload on the evolution of Chagas disease induced by
CL, Y, and YuYu strains of T. cruzi in CFW or gnotobiotic
mice (GN-CFW). The parasitemia was more intense in iron-
dextran-treated, mice and T. cruzi-speciﬁc IgG and IgM
antibody levels were raised in the GN group but not in the
conventional group [101, 102]. This study suggests that the
eﬀects of iron deﬁciency on T. cruzi infection are dependent
on host background and T. cruzi strains, reinforcing the
importance of the genetic diversity of parasites on the
course of infection, as our group and others have previously
demonstrated [103, 104].
More recently, a prolonged treatment with desferrioxam-
ine was tested in experimental model of Chagas disease, in
association or not with the anti-T.cruzi drug, Benznidazole.
It was observed that a decrease of iron in the host leads to
T. cruzi infection attenuation using hemoculture, ELISA or
PCR [105], and iron status of the host inﬂuenced the eﬃcacy
of therapy with Benznidazole and improved the percentage
of infected mice survival [106]. This currently available
nitroimidazole drug, Benznidazole, developed empirically
overthreedecadesago,isunsatisfactoryduetofrequenttoxic
side eﬀects and limited eﬃcacy, particularly during chronic
form of the disease, but this association with a multispec-
trum of new drugs or diet constituents might improve its use
in a low dose with high aﬀectivity against T. cruzi.
Regarding eﬀects of zinc deﬁciency, several studies have
demonstrated the importance of this constituent in the
immune system and in the relationship “parasite/host”
[107, 108]. In zinc deﬁciency, thymic atrophy, lymphopenia,
decreased mitosis, and decreased serum antibodies [109–
111] may occur. In addition, damage can occur in the
mucosal barrier of the gastrointestinal tract and lungs,
increasing susceptibility to fungi, viruses and bacteria infec-
tions [109, 112].
Studies on T. cruzi infection have demonstrated the
eﬀects of zinc supplementation on the response dur-
ing the course of experimental disease [113–115]. These
studies point in the direction that zinc supplementation
enhanced thymocyte and splenocyte proliferation, enhanced
production of IL-12 during the acute phase of infection
[113], and decreased parasitemia load associated with high
levels of IFN-gamma and NO [114, 115]. Braz˜ ao et al.
[116] have demonstrated that zinc, steroid hormone dehy-
droepiandrosterone (DHEA), or zinc and DHEA supple-
mentation enhanced the immune response, as evidenced
by a signiﬁcant reduction in parasitemia levels during the
acute phase of infection in experimental model. Zinc and
DHEA supplementation exerted additive eﬀects on the
immune response by elevation of the number of macrophage
and by increasing concentrations of IFN-gamma and NO.
In addition, Gonc ¸alves-Neto et al. [117] investigated the
eﬀects of zinc sulphate (ZnSO4) supplementation during
pregnancy in mice. For placental parasitism, zinc-supplied
group displayed a signiﬁcant decrease in amastigote nests,
suggesting that zinc was partially eﬀective in upregulating
host immune response against parasite, probably attenuating
the infection in fetuses. Together, these studies suggest
that zinc supplementation leads to upmodulating the host
immune response and contributing to the reduction of
blood parasites and the harmful pathogenic eﬀects of the
experimental Chagas disease.
3.6. Selenium Deﬁciency and T. cruzi Infection. Selenium
is an essential micronutrient for organisms ranging from
bacteria to humans. Acting as an antioxidant at the cellular
level, this diet constituent provides protection against free
radical damage and oxidative stress [118–120]. According toJournal of Tropical Medicine 7
N` eve [121], selenium deﬁciency has been implicated in some
cases of congestive cardiomyopathy and other cardiovascular
complications, including myocardial infarction. Regarding
the study of the eﬀects of selenium deﬁciency on the T. cruzi
infection or its consequence (e.g., Chagas cardiomyopathy),
Rivera et al. [122] investigated whether selenium status
could be involved as a risk factor for the clinical severity
of Chagas heart disease. This study involved 170 patients
clinically stratiﬁed into groups as follows: indeterminate
or asymptomatic (IND), cardiac asymptomatic (CARDa);
cardiac symptomatic with moderate-to-severe heart dys-
function (CARDb), and healthy adults (HA). Selenium
was signiﬁcantly lower in CARDb than in HA, IND, or
CARDa patients, and it presented a positive and signiﬁcant
correlation with ventricular ejection fraction. The decrease
in selenium in chagasic patients seems to be a potential
biological marker for T. cruzi infection and related to the
progression of pathology.
Interestingly, selenium deﬁciency was investigated in
mice experimentally infected with T. cruzi during the
development of the acute myocarditis [123, 124]. Survival
rate was signiﬁcantly lower in selenium deﬁcient than in
control mice, and, at histological evaluation, the severity of
myositis was always more intense in the selenium-deﬁcient
mice concluding that this deﬁciency condition, in murine
model, is able to increase the severity of T. cruzi-induced
myositis and mortality of the animals.
De Souza et al. [125] demonstrated that, although the
selenium supplementation does not lead to a general
protection during infection, it may help protect the heart
from inﬂammatory damage. More recently, De Souza et al.
[126], employing magnetic resonance imaging to noninva-
sively monitor the eﬀect of selenium supplementation on
alterations in the gastrointestinal tract of T. cruzi-infected
mice, suggested that selenium may be used to modulate the
inﬂammatory, immunological, and/or antioxidant responses
involved in intestinal disturbances caused by T. cruzi
infection. In addition, De Souza et al. [127] also showed
that selenium supplementation prevents right ventricular
chamber increase and thus can be proposed as a potential
adjuvant therapy for cardiac alterations already established
by T. cruzi infection.
4. Concluding Remarks
Inthispaper,wediscussedaboutfewevidencesofnutritional
deﬁciencies (PEM and MNM) and their eﬀects on T. cruzi
infection. In this way, protein deﬁciency was shown to delay
recovery of noradrenaline levels that normally occurs during
chronic phase of experimental Chagas disease. Besides, this
protein deﬁciency also decreases resistance to infection and
fails to control parasite replication. Deﬁciencies in iron and
vitamins A, E, B1,B 5,a n dB 6 also exacerbated T. cruzi infec-
tion in experimental models showing correlations between
severity and progression of the disease.
Regarding nutrient supplementation, encouraging re-
sults point to the beneﬁts of vitamin E, zinc, and selenium
supplementation in cases of experimental T. cruzi infection.
In this respect, it is important to emphasize that the choice
of experimental model is an important task to investigate
nutritional deﬁciencies and Chagas disease, in concomitance
or not. Although several animal species have been used
(dogs, mice/rats, monkeys and rabbits), there is still a
lack of consistency in experimental studies and diversity of
methodological.
Despite these limitations, especially those related to
the weak knowledge about mechanisms that govern the
relationship between “nutritional deﬁciencies” and “Chagas
disease,” some issues should be conducted to the encour-
agement of new studies: do PEM and MNM aﬀect the
epidemiology and distribution of Chagas disease? Do PEM
and MNM aﬀect the diagnosis, pathogenesis, and treatment
of this zoonosis? The understanding of immune mechanisms
involved in concomitance of PEM/MNM and Chagas disease
may conduct new prophylactic and therapeutic strategies
to ameliorate impaired responses against T. cruzi and other
adverse eﬀects of PEM/MNM in millions of Central and
South American people.
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